LAKESHORE BIOPHARMA CO LTD (LSB)
KYG9845F1090 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 687.201M | 573.418M -16.56% | 798.92M 39.33% | 1.403B 75.61% | 254.65M -81.85% | 279.9M 9.92% | 343.7M 22.79% | ||
| EBITDA YoY % growth | 30.594M 9.63% | -102.695M -435.67% | -246.231M -139.77% | -9.666M 96.07% | 115.14M 1,291.22% | N/A | N/A | N/A | |
| EBIT YoY % growth | -560K | -139.382M -24,789.71% | -288.417M -106.92% | -183.751M 36.29% | 123.13M 167.01% | 72.822M -40.86% | 92.534M 27.07% | 140.52M 51.86% | |
| Operating Margin | N/A | -20.28% | -50.30% | -23.00% | 8.78% | 28.60% | 33.06% | 40.88% | |
| EPS YoY % growth | N/A | N/A | N/A | -17.98 45.90% | 1.02 105.67% | N/A | N/A | N/A |
All data in CNY
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -6.87 | -5.56 -391.59% | -4.34 47.67% | -1.21 90.96% |
| Revenue Q2Q % growth | 177.58M | 187.17M 93.33% | 201.8M 22.32% | 232.37M 71.68% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A |
All data in CNY
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -13.40 | -5.86 | -7.54 | -128.75% |
| Q3 2024 Q2Q % growth | -8.30 | -5.76 | -2.54 | -44.17% |
| Q2 2024 Q2Q % growth | -1.13 | -0.73 | -0.40 | -55.48% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 135.349M -80.30% | 159.65M | -24.301M | -15.22% |
| Q3 2024 Q2Q % growth | 164.977M | 144.18M | 20.797M | 14.42% |
| Q2 2024 Q2Q % growth | 96.816M | 146.61M | -49.794M | -33.96% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -900% | 0% | -900% |
| Revenue | 0% | 0% | 0% | 0% |